Cibus (CBUS) Free Cash Flow (2016 - 2025)
Cibus (CBUS) posted Free Cash Flow of -$13.5 million for Q4 2025, down 13.55% sequentially from -$11.9 million in Q3 2025, and up 4.02% YoY from -$13.0 million in Q4 2024.
Cibus (CBUS) Free Cash Flow (2016 - 2025) Analysis & Trends
Cibus has reported Free Cash Flow for 10 years, with the latest figure at -$13.5 million in Q4 2025.
- Quarterly Free Cash Flow rose 4.02% year-over-year to -$13.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$51.2 million (up 13.04% YoY) and the FY2025 annual result came in at -$51.2 million, up 13.04% from the prior year.
- Free Cash Flow declined to -$13.5 million in Q4 2025 per CBUS's latest filing, from -$11.9 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$571000.0 in Q2 2021 and troughed at -$18.4 million in Q3 2023.
- A 5-year average of -$10.0 million and a median of -$12.0 million in 2025 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2021 and 2022: Free Cash Flow jumped 95.81% in 2021, then slumped 883.54% in 2022.
- Over 5 years, Free Cash Flow stood at -$4.4 million in 2021, then gained by 13.74% to -$3.8 million in 2022, then tumbled by 362.8% to -$17.5 million in 2023, then grew by 19.55% to -$14.1 million in 2024, then increased by 4.02% to -$13.5 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$13.5 million, -$11.9 million, and -$13.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.49 Mn |
| Dec 31, 2025 | -13.49 Mn |
| Sep 30, 2025 | -11.88 Mn |
| Sep 30, 2025 | -11.88 Mn |
| Jun 30, 2025 | -13.72 Mn |
| Jun 30, 2025 | -13.72 Mn |
| Mar 31, 2025 | -12.09 Mn |
| Mar 31, 2025 | -12.09 Mn |
| Dec 31, 2024 | -14.05 Mn |
| Dec 31, 2024 | -14.05 Mn |
| Sep 30, 2024 | -13.88 Mn |
| Sep 30, 2024 | -13.88 Mn |
| Jun 30, 2024 | -17.22 Mn |
| Jun 30, 2024 | -17.22 Mn |
| Mar 31, 2024 | -13.71 Mn |
| Mar 31, 2024 | -13.71 Mn |
| Dec 31, 2023 | -17.47 Mn |
| Dec 31, 2023 | -17.47 Mn |
| Sep 30, 2023 | -18.39 Mn |
| Sep 30, 2023 | -18.39 Mn |